Showing results (81-90 of 112) with videos related to

Sort By:
Pageof 12
Nature Communications|March 11, 2025
Age-associated differences in mucosal and systemic host responses to SARS-CoV-2 infectionJillian H Hurst, Aditya A Mohan, Trisha Dalapati, et al.
Frontiers in Immunology|December 21, 2023
Multivariate analysis of FcR-mediated NK cell functions identifies unique clustering among humans and rhesus macaquesMarina Tuyishime, Rachel L Spreng, Brady Hueber, et al.
Research Square|April 12, 2022
Differential chromatin accessibility in peripheral blood mononuclear cells underlies COVID-19 disease severity prior to seroconversionNicholas S Giroux, Shengli Ding, Micah T McClain, et al.
Journal of Virology|July 8, 2011
HIV-specific functional antibody responses in breast milk mirror those in plasma and are primarily mediated by IgG antibodiesGenevieve G Fouda, Nicole L Yates, Justin Pollara, et al.
Scientific Reports|July 9, 2022
Differential chromatin accessibility in peripheral blood mononuclear cells underlies COVID-19 disease severity prior to seroconversionNicholas S Giroux, Shengli Ding, Micah T McClain, et al.
Journal of Virology|July 24, 2015
Association of HIV-1 Envelope-Specific Breast Milk IgA Responses with Reduced Risk of Postnatal Mother-to-Child Transmission of HIV-1Justin Pollara, Erin McGuire, Genevieve G Fouda, et al.
Vaccines|April 23, 2025
Computationally Selected Multivalent HIV-1 Subtype C Vaccine Protects Against Heterologous SHIV ChallengeDieter Mielke, Marina Tuyishime, Natasha S Kelkar, et al.
Ebiomedicine|December 7, 2016
Neutralization Takes Precedence Over IgG or IgA Isotype-related Functions in Mucosal HIV-1 Antibody-mediated ProtectionRena D Astronomo, Sampa Santra, Lamar Ballweber-Fleming, et al.
JCI Insight|December 22, 2017
Computational analysis of antibody dynamics identifies recent HIV-1 infectionKelly E Seaton, Nathan A Vandergrift, Aaron W Deal, et al.
Translational Research : the Journal of Laboratory and Clinical Medicine|December 6, 2021
Development of mRNA manufacturing for vaccines and therapeutics: mRNA platform requirements and development of a scalable production process to support early phase clinical trialsJill Whitley, Christopher Zwolinski, Christian Denis, et al.
Pageof 12